[(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-phenylprop-2-enoate

C39H56O2 — CID 14543441

IUPAC[(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-phenylprop-2-enoate
SMILESCC(C)=CCC[C@@H](C)[C@@H]1CC[C@]2(C)C3=C(CC[C@@]12C)[C@@]1(C)CC[C@H](OC(=O)/C=C/c2ccccc2)C(C)(C)[C@@H]1CC3
InChIInChI=1S/C39H56O2/c1-27(2)13-12-14-28(3)30-21-25-39(8)32-18-19-33-36(4,5)34(41-35(40)20-17-29-15-10-9-11-16-29)23-24-37(33,6)31(32)22-26-38(30,39)7/h9-11,13,15-17,20,28,30,33-34H,12,14,18-19,21-26H2,1-8H3/b20-17+/t28-,30+,33+,34+,37-,38+,39-/m1/s1
InChIKeyYNUAVCIRODJHRP-AKWMTVAUSA-N
MW556.88 g/mol
LogP10.74
Rot. Bonds7

About [(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-phenylprop-2-enoate

[(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-phenylprop-2-enoate (PubChem CID 14543441) has the molecular formula C39H56O2 and a molecular weight of 556.88 g/mol. Its IUPAC name is [(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-phenylprop-2-enoate.

Molecular Properties

Compound Name[(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-phenylprop-2-enoate
PubChem CID14543441
Molecular FormulaC39H56O2
Molecular Weight556.88 g/mol
Exact Mass556.43
IUPAC Name[(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-phenylprop-2-enoate
SMILESCC(C)=CCC[C@@H](C)[C@@H]1CC[C@]2(C)C3=C(CC[C@@]12C)[C@@]1(C)CC[C@H](OC(=O)/C=C/c2ccccc2)C(C)(C)[C@@H]1CC3
InChIInChI=1S/C39H56O2/c1-27(2)13-12-14-28(3)30-21-25-39(8)32-18-19-33-36(4,5)34(41-35(40)20-17-29-15-10-9-11-16-29)23-24-37(33,6)31(32)22-26-38(30,39)7/h9-11,13,15-17,20,28,30,33-34H,12,14,18-19,21-26H2,1-8H3/b20-17+/t28-,30+,33+,34+,37-,38+,39-/m1/s1
InChIKeyYNUAVCIRODJHRP-AKWMTVAUSA-N
XLogP10.74
TPSA26.30 Ų
H-Bond Donors
H-Bond Acceptors2
Rotatable Bonds7
Heavy Atoms41
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500556.88
LogP ≤ 510.74
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 102

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze [(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-phenylprop-2-enoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-phenylprop-2-enoate?
The IUPAC name of [(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-phenylprop-2-enoate (CID 14543441) is [(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-phenylprop-2-enoate.
What is the SMILES notation for [(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-phenylprop-2-enoate?
The canonical SMILES for [(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-phenylprop-2-enoate is CC(C)=CCC[C@@H](C)[C@@H]1CC[C@]2(C)C3=C(CC[C@@]12C)[C@@]1(C)CC[C@H](OC(=O)/C=C/c2ccccc2)C(C)(C)[C@@H]1CC3.
What is the InChIKey of [(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-phenylprop-2-enoate?
The InChIKey is YNUAVCIRODJHRP-AKWMTVAUSA-N. The full InChI is InChI=1S/C39H56O2/c1-27(2)13-12-14-28(3)30-21-25-39(8)32-18-19-33-36(4,5)34(41-35(40)20-17-29-15-10-9-11-16-29)23-24-37(33,6)31(32)22-26-38(30,39)7/h9-11,13,15-17,20,28,30,33-34H,12,14,18-19,21-26H2,1-8H3/b20-17+/t28-,30+,33+,34+,37-,38+,39-/m1/s1.
What are the key properties of [(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-phenylprop-2-enoate?
[(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-phenylprop-2-enoate has a molecular weight of 556.88 g/mol, XLogP of 10.74, 7 rotatable bonds, 0 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for [(3S,5R,10S,13S,14S,17S)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-3-phenylprop-2-enoate is sourced from PubChem (CID 14543441), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).